During the past decade, EB House Austria, Department of Dermatology, Paracelsus Medical University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "EB House Austria, Department of Dermatology, Paracelsus Medical University" #1 collaborator was "Paracelsus Medical University" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "EB House Austria, Department of Dermatology, Paracelsus Medical University" are "Junctional Epidermolysis Bullosa" (1 trials) and "Recessive Dystrophic Epidermolysis Bullosa" (1 trials). Many other conditions were trialed in "EB House Austria, Department of Dermatology, Paracelsus Medical University" in a lesser frequency.

Most popular intervention types in "EB House Austria, Department of Dermatology, Paracelsus Medical University" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Genetically corrected cultured epidermal autograft (ATMP)" (1 trials) and "Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP)" (1 trials). Other intervention names were less common.

The vast majority of trials in "EB House Austria, Department of Dermatology, Paracelsus Medical University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "EB House Austria, Department of Dermatology, Paracelsus Medical University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in EB House Austria, Department of Dermatology, Paracelsus Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in EB House Austria, Department of Dermatology, Paracelsus Medical University, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".